Licences issued by the NHMRC Licensing Committee are subject to conditions. The Committee maintains a public database containing particular information in relation to each licence. The database is available on this page.

The Embryo Research Licensing Committee of NHMRC (NHMRC Licensing Committee) is required by section 29 of the Research Involving Human Embryos Act 2002 (RIHE Act) to maintain a public database containing the following information in relation to each licence:

  • the name of the person to whom the licence was issued;
  • a short statement about the uses of excess ART embryos or human eggs, creation or uses of other embryos, that are authorised by the licence;
  • any conditions to which the licence is subject;
  • the number of excess ART embryos or human eggs, and the number of other embryos authorised to be created in respect of which use is authorised by the licence;
  • the date on which the licence was issued; and
  • the period throughout which the licence is to remain in force.

Information made public must not be such as to disclose confidential commercial information.

Licence Conditions

Licences issued by the NHMRC Licensing Committee are subject to conditions. Licences are also subject to the provisions of the RIHE Act and the Prohibition of Human Cloning for Reproduction Act 2002. The sections below describe Standard and Special Licence conditions.

Standard Conditions

The Standard Conditions document is available for download on this page. Standard conditions apply to all licences unless a particular Standard Condition is specifically excluded by the Special Conditions for a licence.

Special Conditions

Special licence conditions relate to a particular licence and include conditions about the number of excess ART embryos or eggs authorised for use, the number of other embryos authorised to be created or used, the people authorised to create and/or use them and the authorised sites, as well as any other special conditions determined by the NHMRC Licensing Committee.

See the table below for details of the licences and Special Conditions.

Current licences issued under s.21 of the Research involving human embryos Act 2002

Licence No. Organisation Licence Title Date of Issue Status
309702b v34 Genea Limited Development of Methods for Preimplantation Genetic and Metabolic Evaluation of Human Embryos 16 April 2004 Currently to 16 April 2019
309703 v41 Genea Limited Development of Human Embryonic Stem (ES) Cells 16 April 2004 Current to 16 April 2019
309710 v32 Genea Limited Derivation of human embryonic stem cells from embryos identified through preimplantation genetic diagnosis to be affected by known serious monogenic conditions 7 May 2007 Current to 7 May 2019
309718 v21 Genea Limited Use of excess ART embryos and clinically unusable eggs for validation of an IVF device 8 December 2011 Current to 8 December 2018
309719 v19 Genea Limited Use of excess ART embryos for the development of improved IVF culture media 28 March 2012 Current to 28 March 2021
309723 v11 Melbourne IVF Pty Ltd Use of excess ART embryos for blastocyst-stage biopsy training 19 December 2014 Current to 19 December 2020
309724 v3 IVFAustralia Pty Ltd Use of excess ART embryos for blastocyst-stage biopsy training 21 April 2017 21 April 2020
309725 v3 TasIVF Pty Ltd Use of excess ART embryos for blastocyst-stage embryo biopsy training 1 September 2017 1 September 2020

Expired Licences 

Licence No. Organisation Licence Title Date of issue Status
309700 v3 Monash IVF Use of excess ART embryos for training in embryo biopsy 11 March 2005 Expired
309701 v20 Sydney IVF Improvement in laboratory conditions for embryo culture 16 April 2004 Expired
309702A v19 Sydney IVF Effect of an additive on embryo culture: analysis of growth and epigenetic programming 16 April 2004 Expired
309704 v8 Melbourne IVF Pty Ltd Development of testing procedures for unbalanced chromosome errors in human embryos 16 April 2004 Expired
309712v15 Genea Limited Reproducible production of human embryonic stem cell lines from somatic cell nuclear transfer (SCNT) of nuclei from human cumulus cells into clinically unusable human eggs. 16 September 2008 Expired
309713v15 Genea Limited Reproducible production of human embryonic stem cell lines from somatic cell nuclear transfer (SCNT) of nuclei from adult human fibroblasts into clinically unusable human eggs. 16 September 2008 Expired
309714v15 Genea Limited Reproducible production of human embryonic stem cell lines from somatic cell nuclear transfer (SCNT) of nuclei from previously established human embryonic stem cell lines into clinically unusable human eggs. 16 September 2008 Expired
309707v5 Monash University Derivation of embryonic stem cell lines from the human embryo 21 December 2004 Expired
309708v6 IVF Australia Pty Ltd A collaborative project between IVF Australia and the Diabetes Transplant Unit, Prince of Wales Hospital to derive human embryonic stem cell lines for the treatment of diabetes 5 November 2004 Expired
309709v9 Melbourne IVF Pty Ltd A collaborative project between Melbourne IVF Pty Ltd and Stem Cell Sciences Pty Ltd to derive human embryonic stem cell lines 11 June 2004 Expired
309716v5 Fertility Australia Trust trading as Fertility East Assisted Conception Clinic and Monash Institute of Medical Research Production of human embryonic stem cell lines from parthenogenetic activation of matured human eggs obtained from clinically unusable human eggs 29 June 2011 Expired
309720v3 Fertility Australia Trust trading as Fertility East Assisted Conception Clinic and Division of Biological Engineering, Faculty of Engineering, Monash University Production of human embryonic stem cell lines from parthenogenetic activation of human eggs obtained from ovaries removed prophylactically from women at risk for developing cancer 15 July 2013 Expired

309722 v6

Monash IVF Pty Ltd Optimising embryo-endometrial interactions to improve pregnancy success during IVF 11 December 2013 Expired